We recently published a list of 10 Stocks Drop The Most Amid Investor Caution. In this article, we are going to take a look ...

HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into ...

Summit Therapeutics (NASDAQ:SMMT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC ...

We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...

Summit Therapeutics Inc (SMMT) reports a robust cash reserve and debt-free status, while advancing key clinical trials and ...

Q4 2024 Earnings Call Transcript February 24, 2025 Operator: Good morning and welcome to Summit Therapeutics Fourth Quarter ...

This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

Shares of NASDAQ:SMMT opened at $18.30 on Monday. Summit Therapeutics has a 12-month low of $2.10 and a 12-month high of $33.89. The company’s fifty day moving average is $19.93 and its two ...

Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for Summit Therapeutics in a research note issued on Tuesday ...

SMMT opened at $18.30 on Tuesday. Summit Therapeutics has a one year low of $2.10 and a one year high of $33.89. The stock has a market cap of $13.50 billion, a price-to-earnings ratio of -65.35 ...